John R Fischer

Avista, BC Partners, Hamilton Lane bet on generic pharma; Changes to US healthcare market already in motion, says Stout

Healthcare services M&A is expected to pick up in the coming months, according to new data.

PE eyes generic pharma investment opportunities: 5 deals

Avista Healthcare Partners, BC Partners, Hamilton Lane and Kartesia are among the PE firms investing in the generic pharmaceutical sector.

Hospice care's fragmentation makes it ripe for PE consolidation

Osceola, Renovus and Vistria aim to create regional leaders in end-of-life care.

Ares, CD&R and Neuberger Berman target retail apparel; Life science companies ripe for PE investment

Private equity bets on footwear.

Dealmakers positive on M&A under new administration, Aon survey finds; Fintech M&A shows robustness

A majority of surveyed PE pundits are anticipating deal activity to grow in 2025.

Amulet, CVC and Kinderhook pursue primary care; shift in value-based care drives PE investments, says Harris Williams

Private equity sees ample opportunity in the primary care market.

PE sees consolidation opportunities in primary care market: 5 deals

Amulet Capital Partners, CVC and Kinderhook Industries are among the PE firms investing in primary care facilities and service organizations.

Munich Re’s Gregory Schmitt on selecting the right manager; H&F, Main Capital, TA Associates target smart car software

Private equity bets on automotive tech.

More states could scrutinize PE healthcare deals, says McDermott's Kitchell

'There's a lot of optimism and desire to do transactions but still uncertainty around completing deals, especially since much of healthcare is on a local level,' said McDermott's Sarah Kitchell.

Apollo, BC Partners, EQT pursue waste management deals; Provident expects healthcare deal volume to rise

Private equity bets on waste management.